Your session is about to expire
← Back to Search
Behavioral Intervention
Exercise with Blood Flow Restriction for Fitness Improvement
N/A
Waitlist Available
Led By Martin Senechal, PhD
Research Sponsored by University of New Brunswick
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 6 weeks post-intervention and pre and post an acute bout of resistance training at baseline and and after 6 weeks
Awards & highlights
Study Summary
This trial looks at how resistance training combined with blood flow restriction affects fat-free mass and physical performance in male and female non-active people.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 6 weeks post-intervention and pre and post an acute bout of resistance training at baseline and and after 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 6 weeks post-intervention and pre and post an acute bout of resistance training at baseline and and after 6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Hypertrophy
Secondary outcome measures
Body Weight Changes
Changes in physical function
Muscle Tissue
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Young adult (19-30 years)Experimental Treatment1 Intervention
Individuals aged 19-30 who are not physically active will participate in resistance training combined with blood flow restriction.
Group II: Older adults adult (aged 65 years and older)Experimental Treatment1 Intervention
Individuals aged 65 years and older who are not physically active will participate in resistance training combined with blood flow restriction.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resistance Training with Blood flow restriction
2022
N/A
~80
Find a Location
Who is running the clinical trial?
University of New BrunswickLead Sponsor
22 Previous Clinical Trials
2,486 Total Patients Enrolled
Public Health Agency of Canada (PHAC)OTHER_GOV
46 Previous Clinical Trials
94,873 Total Patients Enrolled
Martin Senechal, PhDPrincipal InvestigatorUniversity of New Brunswick
3 Previous Clinical Trials
126 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You don't get enough exercise, but you're generally in good health.You have high blood pressure that is not being properly managed.You are taking medications that can increase your risk of blood clots.You are either too young or too old to participate in the study.You have cardiovascular disease.You are pregnant.You had surgery, bone fracture, or skin graft within the last three months.
Research Study Groups:
This trial has the following groups:- Group 1: Young adult (19-30 years)
- Group 2: Older adults adult (aged 65 years and older)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger